A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocolNicholas F. Brown, Paul Mulholland, Corran Roberts et al.|BMC Cancer|2020Cited by 51
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC)Karin Purshouse, Jeremy Crew, Victoria K. Woodcock et al.|European Urology Supplements|2019Cited by 1